US 10357484
Heterocyclic compound
granted A61KA61K31/4035A61K31/4245
Quick answer
US patent 10357484 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/4035, A61K31/4245, A61K31/427, A61K31/437